6/17/2025
The role of parathyroid hormone-related peptide and its receptor as an autocrine/paracrine effector system in human neoplasia Technical aspects of immunohistochemical methodology
6/17/2025
Targeted therapy: by serendipity, we identified a novel oncogene, and found that multiple cancers are addicted to its activity. This oncogene addiction is evidenced in glioblastoma, pediatric sarcoma, and others.…
6/17/2025
My research interests focus on three major areas: 1- Hypothalamic, pituitary and peripheral interactions in the pathogenesis of pituitary adenomas; 2 - Refinement of the morphologic and immunohistochemical techniques for…
6/17/2025
UNLEASH: We work on cytokine control of memory lymphocytes, with a particular interest in the molecular regulators of vaccination and pathological antibodies in different disease states. Experimentally, we use i) mouse…
6/17/2025
Our research is in the field of human genetics. Specifically, we are studying the molecular genetics and biology of myotonic dystrophy (DM), the most common inherited neuromuscular disorder in adults.…
6/17/2025
6/17/2025
My research interests center around the use of molecular and immunohistochemical techniques to improve cancer diagnosis and prognostication with specific interest in uterine neoplasia, gyneologic heritable cancer syndromes, and human…
6/17/2025
Clinicopathologic correlations of neoplasia; identification of diagnostically and prognostically relevant morphologic features in neoplasms; development and evaluation of tumor-derived and tumor-specific immunohistochemical markers.
6/17/2025
Genomic analysis of primary human cancer specimens for global genetic and gene expression alterations. Development of model systems to validate biological roles of candidate genes. Translation of experimental findings to…
6/17/2025
Differential diagnosis in dermatopathology, with special interests in malignant melanoma, cutaneous T cell lymphoma, and other cutaneous malignancies, panniculitis, opportunistic infections, and immunofluorescence studies.
